BMS’ Opdivo fails late-stage brain cancer test

Al's Comment:

  There are many ways to use the checkpoint inhibitors.  This study shows that using Opdivo instead of Temodar during radiation for newly diagnosed is not helping.  This doesn't mean the drug is bad - just that it isn't being used correctly.  There are other trials going on that hopefully will show us how best to use this class of drug!


Posted on: 05/13/2019

BMS’ Opdivo fails late-stage brain cancer test

 


Click HERE to return to brain tumor news headlines